查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1769746

2025年性行为感染传染病（STD）检测全球市场报告

Sexually Transmitted Diseases (STD) Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年性行为感染传染病 (STD) 检测市场规模将强劲成长，到 2029 年将达到 120.8 亿美元，年复合成长率（CAGR）为 8.3%。这一增长由一系列关键驱动因素推动，包括全球性传染病盛行率上升、性健康意识增强、无症状感染率高、性活跃青少年和年轻人数量增加以及危险性行为激增。预测的主要趋势包括快速和就地检验的兴起、家用性传染病检测套组的出现、分子诊断技术的进步、诊断实验室自动化和人工智慧整合度的提高以及新型检测套组准确性和可靠性的提高。

预计爱滋病毒感染率的上升将在未来几年推动性行为感染传染病 (STD) 检测市场的成长。爱滋病毒攻击并破坏重要的白血球，从而削弱免疫系统，使人们更容易受到感染疾病和疾病的侵害。爱滋病毒病例的增加导致更多的人采取无保护性行为等危险行为，而接受检测的人越来越少，尤其是年轻人。爱滋病毒病例的增加提高了公众和医疗相关人员的认识，导致更多的人接受全面检测以儘早发现感染并防止进一步传播。例如，根据联合国爱滋病毒联合规划署 (UNAIDS) 2024 年 7 月的数据，2023 年新增爱滋病毒感染者约有 130 万，几乎是 2025 年低于 37 万的目标的三倍。因此，预计爱滋病毒感染率的上升将推动对性传染病检测的需求。

为了提高可及性和准确性，性行为感染传染病 (STD) 检测市场的主要参与者正专注于开发梅毒检测套组等先进解决方案。这些套件使用血液和其他体液来检测梅毒的病原体梅毒螺旋体，以便能够及时诊断和治疗。例如，2023 年 8 月，美国医疗设备公司 iHealth Labs Inc. 推出了 HIV 和梅毒检测的 CheckMeSafe 家用采集试剂套件。这款经 FDA 批准的套件允许 18 岁及以上的个人在家中采集血液样本进行 HIV（i、ii、P24 抗原）和梅毒检测。使用者可以使用预付的隔夜标籤将样本送到实验室，并在短短两天内收到保密、可靠的结果。套件对 HIV 的敏感度达到 99.9%，对梅毒的敏感度达到 99.5%，具有很高的准确性。所有样本均在 CLIA 认证和 CAP 认可的实验室进行测试，定期测试确保符合严格的联邦和州品质标准。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球性行为感染传染病 (STD) 检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球性行为感染传染病（STD）检测市场：成长率分析
  • 全球性行为感染传染病 (STD) 检测市场表现：规模与成长，2019-2024 年
  • 全球性行为感染传染病 (STD) 检测市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球性行为感染传染病（STD）检测：总目标市场（TAM）

第六章市场区隔

  • 全球性行为感染传染病 (STD) 检测市场（按产品、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 设备和服务
  • 耗材
  • 软体
  • 全球性行为感染传染病 (STD) 检测市场（按技术、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 免疫检测
  • 分子诊断
  • 全球性行为感染传染病 (STD) 检测市场（按样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 血液样本
  • 尿液样本
  • 棉花棒
  • 精液样本
  • 其他样本类型
  • 全球性行为感染传染病 (STD) 检测市场（按疾病类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 披衣菌感染
  • 淋病
  • 梅毒
  • HIV或爱滋病
  • 单纯疱疹病毒（HSV）
  • 全球性行为感染传染病 (STD) 检测市场（按最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 个人
  • 医疗保健提供者
  • 健康保险公司
  • 政府卫生机构
  • 非政府组织和社区健康组织
  • 全球性行为感染传染病 (STD) 检测市场、设备和服务、按类型细分：实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断设备
  • 测试服务
  • 全球性行为感染传染病 (STD) 检测市场、耗材、按类型细分：实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂和套件
  • 检体装置
  • 玻片、试管和其他实验室用品
  • 全球性行为感染传染病 (STD) 检测市场、软体、按类型细分：实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 实验室资讯管理系统（LIMS）
  • 电子健康记录 (EHR) 整合工具
  • 数据分析和报告工具
  • 病人管理软体

第七章 区域和国家分析

  • 全球性行为感染传染病 (STD) 检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球性行为感染传染病 (STD) 检测市场：按国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 性行为感染传染病（STD）检测市场：竞争格局
  • 性行为感染传染病（STD）检测市场：公司简介
    • F Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson And Co. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Hologic Inc.
  • QuidelOrtho Corp.
  • Bio-Rad Laboratories Inc.
  • Cepheid
  • OraSure Technologies Inc.
  • Meridian Bioscience Inc.
  • Sekisui Diagnostics Ltd.
  • Trinity Biotech Plc
  • Chembio Diagnostics Inc.
  • Operon SA
  • Jal Medical Pte. Ltd.
  • Anatolia Geneworks
  • CLIAwaived Inc.
  • Avecon Healthcare Pvt. Ltd.
  • AEHEALTH LIMITED

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年性行为感染传染病（STD）检测市场：提供新机会的国家
  • 2029年性行为感染传染病（STD）检测市场：细分市场带来新机会
  • 2029年性行为感染传染病（STD）检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r36063

Sexually transmitted disease (STD) testing refers to the medical procedure used to detect infections primarily transmitted through sexual contact. It is essential for early diagnosis, which helps prevent complications and controls the spread of infections through timely treatment and counseling. Regular screening is often advised for sexually active individuals since many infections may not present immediate symptoms but can still be contagious.

The main components of sexually transmitted disease (STD) testing include instruments and services, consumables, and software. Instruments and services comprise the diagnostic devices and support activities utilized in clinical environments for conducting medical tests. These employ both immunoassay and molecular diagnostic technologies and can analyze blood, urine, swabs, semen, and other sample types. This testing is applied for various diseases such as chlamydia, gonorrhea, syphilis, HIV/AIDS, and herpes simplex virus (HSV), serving a range of end users including individuals, healthcare providers, health insurers, government health agencies, NGOs, and community health organizations.

The sexually transmitted diseases (STD) testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted diseases (STD) testing market statistics, including sexually transmitted diseases (STD) testing industry global market size, regional shares, competitors with a sexually transmitted diseases (STD) testing market share, detailed sexually transmitted diseases (STD) testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted diseases (STD) testing industry. This sexually transmitted diseases (STD) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted diseases (STD) testing market size has grown strongly in recent years. It will grow from $8.08 billion in 2024 to $8.78 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. Growth during the past years has been driven by increasing urbanization and population density, a growing aging population maintaining active sexual lifestyles, government efforts to promote STD screening, the integration of STD testing into routine health examinations, and greater funding for public health initiatives.

The sexually transmitted diseases (STD) testing market size is expected to see strong growth in the next few years. It will grow to $12.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. This anticipated expansion can be credited to the rising global incidence of STDs, enhanced awareness of sexual health issues, the high rate of infections without symptoms, the increasing number of sexually active adolescents and young adults, and a surge in risky sexual behaviors. Key trends forecasted include the rise of rapid and point-of-care testing, the emergence of home-based STD testing kits, progress in molecular diagnostic methods, greater automation and AI integration in diagnostic labs, and improved accuracy and reliability of new testing kits.

The increasing prevalence of HIV is expected to drive the growth of the sexually transmitted diseases (STD) testing market in the upcoming years. HIV attacks and destroys vital white blood cells, weakening the immune system and making the body more susceptible to infections and diseases. The rise in HIV cases is linked to a decline in awareness and prevention efforts, leading to more individuals engaging in risky behaviors such as unprotected sex and fewer people, especially youth, getting tested. This increase in HIV cases has raised public and healthcare awareness, encouraging more people to seek comprehensive testing to detect infections early and prevent further spread. For example, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in July 2024, approximately 1.3 million people were newly infected with HIV in 2023, nearly three times higher than the 2025 target of fewer than 370,000 cases. Therefore, the growing prevalence of HIV is expected to enhance the demand for STD testing.

Key players in the sexually transmitted diseases (STD) testing market are focusing on the development of advanced solutions, such as syphilis testing kits, to improve accessibility and accuracy. These kits detect the Treponema pallidum bacteria, which causes syphilis, using blood or other bodily fluids, enabling timely diagnosis and treatment. For instance, in August 2023, iHealth Labs Inc., a US medical device company, launched the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit allows individuals aged 18 and older to collect blood samples at home for HIV (I, II, P24 antigen) and syphilis testing. Users can send their samples to the lab with a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers high accuracy, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are tested in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with stringent federal and state quality standards through regular inspections.

In December 2023, imaware, a US-based company providing at-home health testing kits, acquired binx health's at-home consumer testing division. This acquisition will help imaware strengthen its position in the growing home-health testing market and expand its enterprise client base. Meanwhile, binx health will continue to develop and grow its point-of-care molecular diagnostics division, which was not part of the acquisition. Binx health is a US-based provider of sexually transmitted disease (STD) testing solutions.

Major players in the sexually transmitted diseases (std) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., and AEHEALTH LIMITED.

North America was the largest region in the sexually transmitted diseases (STD) testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted diseases (STD) testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted diseases (STD) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted diseases (STD) testing market consists of revenues earned by entities by providing services such as confidential testing, walk-in clinic testing, online test ordering, telehealth consultations, and partner notification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted diseases (STD) testing market also includes sales of at-home test kits, multi-infection panel kits, blood collection devices, biohazard specimen bags, and portable sample storage containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Diseases (STD) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted diseases (std) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted diseases (std) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sexually transmitted diseases (std) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments And Services; Consumables; Software
  • 2) By Technology: Immunoassay; Molecular Diagnostics
  • 3) By Sample Type: Blood Samples; Urine Samples; Swabs; Semen Samples; Other Sample Types
  • 4) By Disease Type: Chlamydia; Gonorrhea; Syphilis; HIV Or AIDS; Herpes Simplex Virus (HSV)
  • 5) By End User: Individuals; Healthcare Providers; Health Insurance Providers; Govement Health Agencies; NGOs And Community Health Organizations
  • Subsegments:
  • 1) By Instruments And Services: Diagnostic Instruments; Testing Services
  • 2) By Consumables: Reagents And Kits; Specimen Collection Devices; Slides, Tubes, And Other Lab Supplies
  • 3) By Software: Laboratory Information Management Systems (LIMS); Electronic Health Records (EHR) Integration Tools; Data Analysis And Reporting Tools; Patient Management Software
  • Companies Mentioned: F Hoffmann La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Siemens Healthineers AG; Becton Dickinson And Co.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sexually Transmitted Diseases (STD) Testing Market Characteristics

3. Sexually Transmitted Diseases (STD) Testing Market Trends And Strategies

4. Sexually Transmitted Diseases (STD) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sexually Transmitted Diseases (STD) Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sexually Transmitted Diseases (STD) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sexually Transmitted Diseases (STD) Testing Market Growth Rate Analysis
  • 5.4. Global Sexually Transmitted Diseases (STD) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sexually Transmitted Diseases (STD) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sexually Transmitted Diseases (STD) Testing Total Addressable Market (TAM)

6. Sexually Transmitted Diseases (STD) Testing Market Segmentation

  • 6.1. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments And Services
  • Consumables
  • Software
  • 6.2. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay
  • Molecular Diagnostics
  • 6.3. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Samples
  • Urine Samples
  • Swabs
  • Semen Samples
  • Other Sample Types
  • 6.4. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chlamydia
  • Gonorrhea
  • Syphilis
  • HIV Or AIDS
  • Herpes Simplex Virus (HSV)
  • 6.5. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Individuals
  • Healthcare Providers
  • Health Insurance Providers
  • Govement Health Agencies
  • NGOs And Community Health Organizations
  • 6.6. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Instruments And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Instruments
  • Testing Services
  • 6.7. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Kits
  • Specimen Collection Devices
  • Slides, Tubes, and Other Lab Supplies
  • 6.8. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Information Management Systems (LIMS)
  • Electronic Health Records (EHR) Integration Tools
  • Data Analysis And Reporting Tools
  • Patient Management Software

7. Sexually Transmitted Diseases (STD) Testing Market Regional And Country Analysis

  • 7.1. Global Sexually Transmitted Diseases (STD) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sexually Transmitted Diseases (STD) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market

  • 8.1. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sexually Transmitted Diseases (STD) Testing Market

  • 9.1. China Sexually Transmitted Diseases (STD) Testing Market Overview
  • 9.2. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sexually Transmitted Diseases (STD) Testing Market

  • 10.1. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sexually Transmitted Diseases (STD) Testing Market

  • 11.1. Japan Sexually Transmitted Diseases (STD) Testing Market Overview
  • 11.2. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sexually Transmitted Diseases (STD) Testing Market

  • 12.1. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sexually Transmitted Diseases (STD) Testing Market

  • 13.1. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sexually Transmitted Diseases (STD) Testing Market

  • 14.1. South Korea Sexually Transmitted Diseases (STD) Testing Market Overview
  • 14.2. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sexually Transmitted Diseases (STD) Testing Market

  • 15.1. Western Europe Sexually Transmitted Diseases (STD) Testing Market Overview
  • 15.2. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sexually Transmitted Diseases (STD) Testing Market

  • 16.1. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sexually Transmitted Diseases (STD) Testing Market

  • 17.1. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sexually Transmitted Diseases (STD) Testing Market

  • 18.1. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sexually Transmitted Diseases (STD) Testing Market

  • 19.1. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sexually Transmitted Diseases (STD) Testing Market

  • 20.1. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market

  • 21.1. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market Overview
  • 21.2. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sexually Transmitted Diseases (STD) Testing Market

  • 22.1. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sexually Transmitted Diseases (STD) Testing Market

  • 23.1. North America Sexually Transmitted Diseases (STD) Testing Market Overview
  • 23.2. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sexually Transmitted Diseases (STD) Testing Market

  • 24.1. USA Sexually Transmitted Diseases (STD) Testing Market Overview
  • 24.2. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sexually Transmitted Diseases (STD) Testing Market

  • 25.1. Canada Sexually Transmitted Diseases (STD) Testing Market Overview
  • 25.2. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sexually Transmitted Diseases (STD) Testing Market

  • 26.1. South America Sexually Transmitted Diseases (STD) Testing Market Overview
  • 26.2. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sexually Transmitted Diseases (STD) Testing Market

  • 27.1. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sexually Transmitted Diseases (STD) Testing Market

  • 28.1. Middle East Sexually Transmitted Diseases (STD) Testing Market Overview
  • 28.2. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sexually Transmitted Diseases (STD) Testing Market

  • 29.1. Africa Sexually Transmitted Diseases (STD) Testing Market Overview
  • 29.2. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sexually Transmitted Diseases (STD) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Sexually Transmitted Diseases (STD) Testing Market Competitive Landscape
  • 30.2. Sexually Transmitted Diseases (STD) Testing Market Company Profiles
    • 30.2.1. F Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson And Co. Overview, Products and Services, Strategy and Financial Analysis

31. Sexually Transmitted Diseases (STD) Testing Market Other Major And Innovative Companies

  • 31.1. Hologic Inc.
  • 31.2. QuidelOrtho Corp.
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Cepheid
  • 31.5. OraSure Technologies Inc.
  • 31.6. Meridian Bioscience Inc.
  • 31.7. Sekisui Diagnostics Ltd.
  • 31.8. Trinity Biotech Plc
  • 31.9. Chembio Diagnostics Inc.
  • 31.10. Operon SA
  • 31.11. Jal Medical Pte. Ltd.
  • 31.12. Anatolia Geneworks
  • 31.13. CLIAwaived Inc.
  • 31.14. Avecon Healthcare Pvt. Ltd.
  • 31.15. AEHEALTH LIMITED

32. Global Sexually Transmitted Diseases (STD) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Diseases (STD) Testing Market

34. Recent Developments In The Sexually Transmitted Diseases (STD) Testing Market

35. Sexually Transmitted Diseases (STD) Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer